BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas
- 1 June 2006
- Vol. 38 (3) , 201-204
- https://doi.org/10.1080/00313020600696264
Abstract
We aimed to determine the BRAF mutation and AKAP9 expression in papillary thyroid carcinomas (PTCs). In this study, we analysed 100 sporadic PTC specimens and we detected mutation in 62.2% of the conventional type PTCs (51/82), in 50% of the follicular variant type PTCs (3/6), in 50% of the diffuse sclerosing variant type PTCs (1/2), and in 30% of the microcarcinomas (3/10). All mutations involved a T→A transversion at the nucleotide 1796. The cases with BRAF mutation were significantly associated with extrathyroidal extension. We also evaluated the expression of AKAP9 protein by immunohistochemistry. The AKAP9 protein was seen as a single perinuclear dot in all the PTCs. Therefore, 58% of the specimens harboured the BRAF mutation and no case had AKAP9-BRAF fusion in the sporadic PTCs. Our results suggest that the BRAF mutation can be a useful diagnostic and prognostic marker and a target for exploring novel cancer therapies to treat PTCs. AKAP9- BRAF fusion may be a very rare event in sporadic PTCs.Keywords
This publication has 19 references indexed in Scilit:
- BRAF mutations in an Italian cohort of thyroid cancersClinical Endocrinology, 2004
- BRAFV599EMutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid CarcinomasJournal of Clinical Endocrinology & Metabolism, 2004
- BRAF T1796A Transversion Mutation in Various Thyroid NeoplasmsJournal of Clinical Endocrinology & Metabolism, 2004
- Mutations of the BRAF Gene in Papillary Thyroid Carcinoma in a Korean PopulationYonsei Medical Journal, 2004
- BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary CarcinomasJournal of Clinical Endocrinology & Metabolism, 2003
- BRAF mutations in papillary carcinomas of the thyroidOncogene, 2003
- Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid CancersJournal of Clinical Endocrinology & Metabolism, 2003
- BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTCOncogene, 2003
- BRAF Mutation in Papillary Thyroid CarcinomaJNCI Journal of the National Cancer Institute, 2003
- Mutations of the BRAF gene in human cancerNature, 2002